No Covid-19 deaths recorded in UK for first time since pandemic began

Moderna announced it has begun applying for full approval for its Covid-19 vaccine in people ages 18 and up.

The company says it will continue to submit trial data “on a rolling basis over the coming weeks with a request for a Priority Review.” A priority review asks the US Food and Drug Administration to take action within six months, compared to the 10 months designated under standard review.